- Home
- EXEL vs MNSO Comparison
EXEL vs MNSO Comparison
Compare EXEL & MNSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- MNSO
- Stock Information
- Founded
- EXEL 1994
- MNSO 2013
- Country
- EXEL United States
- MNSO China
- Employees
- EXEL N/A
- MNSO N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- MNSO Department/Specialty Retail Stores
- Sector
- EXEL Health Care
- MNSO Consumer Discretionary
- Exchange
- EXEL Nasdaq
- MNSO Nasdaq
- Market Cap
- EXEL 9.7B
- MNSO 7.8B
- IPO Year
- EXEL 2000
- MNSO 2020
- Fundamental
- Price
- EXEL $36.20
- MNSO $23.55
- Analyst Decision
- EXEL Buy
- MNSO Hold
- Analyst Count
- EXEL 17
- MNSO 4
- Target Price
- EXEL $35.50
- MNSO $20.90
- AVG Volume (30 Days)
- EXEL 2.5M
- MNSO 1.1M
- Earning Date
- EXEL 02-04-2025
- MNSO 03-11-2025
- Dividend Yield
- EXEL N/A
- MNSO 2.40%
- EPS Growth
- EXEL 441.02
- MNSO 2.83
- EPS
- EXEL 1.55
- MNSO 1.23
- Revenue
- EXEL $2,081,598,000.00
- MNSO $2,501,784,871.00
- Revenue This Year
- EXEL $20.53
- MNSO $14.75
- Revenue Next Year
- EXEL $0.95
- MNSO $22.00
- P/E Ratio
- EXEL $23.39
- MNSO $19.11
- Revenue Growth
- EXEL 17.31
- MNSO 9.45
- 52 Week Low
- EXEL $20.02
- MNSO $12.51
- 52 Week High
- EXEL $37.59
- MNSO $27.71
- Technical
- Relative Strength Index (RSI)
- EXEL 58.54
- MNSO 50.29
- Support Level
- EXEL $33.05
- MNSO $22.53
- Resistance Level
- EXEL $37.59
- MNSO $23.83
- Average True Range (ATR)
- EXEL 0.99
- MNSO 0.80
- MACD
- EXEL 0.28
- MNSO -0.37
- Stochastic Oscillator
- EXEL 69.38
- MNSO 19.59
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About MNSO MINISO Group Holding Limited
MINISO Group Holding Ltd is a retailer offering a variety of design-led lifestyle products. The principal activity of the Company is investment holding. The company's product categories include home decor, small electronics, textiles, accessories, beauty tools, toys, cosmetics, personal care, snacks, fragrance and perfumes, and stationery and gifts. Its segment includes the MINISO brand, which is engaged in the Design, buying and sale of lifestyle products, and the TOP TOY brand, which is engaged in the Design, buying and sale of pop toys. The company generates maximum revenue from the MINISO brand segment. Geographically, it derives a majority of its revenue from China.